BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells

Cell Cycle

Volumn 13, Issue 18, 2014, Pages 2869-2878

  Wu, Shu ^a,b,c   Ge, Yuanlong ^b   Huang, Laiqiang ^a,c   Liu, Haiying ^b   Xue, Yong ^d   Zhao, Yong ^b  

^a TSINGHUA UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Center for Biotech and Bio Medicine   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BRG1; Chromatin remodeling; HDACs; Telomerase; Telomeres; catenin

Indexed keywords

BETA CATENIN; BRG1 PROTEIN; HISTONE DEACETYLASE 2; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE SETD1A; MESSENGER RNA; SMALL INTERFERING RNA; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LIMIT OF QUANTITATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TELOMERE; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; UTERINE CERVIX CANCER; WESTERN BLOTTING;

EID: 84908179266     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.946834     Document Type: Article

References (52)

1. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-10; PMID:16166375; http://dx.doi.org/10.1101/gad.1346005
2. Miller AS, Balakrishnan L, Buncher NA, Opresko PL, Bambara RA. Telomere proteins POT1, TRF1 and TRF2 augment long-patch base excision repair in vitro. Cell Cycle 2012; 11:998-1007; PMID: 22336916; http://dx.doi.org/10.4161/cc.11.5.19483
3. Xin H, Liu D, Wan M, Safari A, Kim H, Sun W, O'Connor MS, Songyang Z. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007; 445:559-62; PMID: 17237767; http://dx.doi.org/10.1038/nature05469
4. Houghtaling BR, Canudas S, Smith S. A role for sister telomere cohesion in telomere elongation by telomerase. Cell Cycle 2012; 11:19-25; PMID: 22157096; http://dx.doi.org/10.4161/cc.11.1.18633
5. Mitchell TR, Zhu XD. Methylated TRF2 associates with the nuclear matrix and serves as a potential biomarker for cellular senescence. Aging (Albany NY) 2014; 6:248-63; PMID:24721747
6. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458-60; PMID:2342578; http://dx.doi.org/10.1038/345458a0
7. Chow TT, Zhao Y, Mak SS, Shay JW, Wright WE. Early and late steps in telomere overhang processing in normal human cells: the position of the final RNA primer drives telomere shortening. Genes Dev 2012; 26:1167-78; PMID:22661228; http://dx.doi.org/10.1101/gad.187211.112
8. Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005; 26:867-74; PMID:15471900; http://dx.doi.org/10.1093/carcin/bgh296
9. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5; PMID:7605428; http://dx.doi.org/10.1126/science.7605428
10. Greider CW. Telomeres, telomerase and senescence. Bioessays 1990; 12:363-9; PMID:2241933; http://dx.doi.org/10.1002/bies.950120803
11. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002; 66:407-25, table of contents; PMID:12208997; http://dx.doi.org/10.1128/MMBR.66.3.407-425.2002
12. Ito H, Kyo S, Kanaya T, Takakura M, Inoue M, Namiki M. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 1998; 4:1603-8; PMID: 9676833
13. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998; 58:1558-61; PMID:9537264
14. Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 1999; 8:137-42; PMID:9887342; http://dx.doi.org/10.1093/hmg/8.1.137
15. Horikawa I, Cable PL, Afshari C, Barrett JC. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 1999; 59:826-30; PMID:10029071
16. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999; 59:551-7; PMID: 9973199
17. Cukusic A, Skrobot Vidacek N, Sopta M, Rubelj I. Telomerase regulation at the crossroads of cell fate. Cytogenet Genome Res 2008; 122:263-72; PMID: 19188695; http://dx.doi.org/10.1159/000167812
18. Sanduja S, Kaza V, Dixon DA. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase. Aging (Albany NY) 2009; 1:803-17; PMID:20157568
19. Hargreaves DC, Crabtree GR. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res 2011; 21:396-420; PMID:21358755; http://dx.doi.org/10.1038/cr.2011.32
20. Tyler JK, Kadonaga JT. The "dark side" of chromatin remodeling: repressive effects on transcription. Cell 1999; 99:443-6; PMID:10589670; http://dx.doi.org/10.1016/S0092-8674(00)81530-5
21. Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000; 60:6171-7; PMID:11085541
22. Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011; 11:481-92; PMID:21654818; http://dx.doi.org/10.1038/nrc3068
23. Bultman SJ, Herschkowitz JI, Godfrey V, Gebuhr TC, Yaniv M, Perou CM, Magnuson T. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 2008; 27:460-8; PMID:17637742; http://dx.doi.org/10.1038/sj.onc.1210664
24. Barker N, Hurlstone A, Musisi H, Miles A, Bienz M, Clevers H. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. Embo J 2001; 20:4935-43; PMID: 11532957; http://dx.doi.org/10.1093/emboj/20.17. 4935
25. Griffin CT, Curtis CD, Davis RB, Muthukumar V, Magnuson T. The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels. Proc Natl Acad Sci U S A 2011; 108:2282-7; PMID: 21262838;http://dx.doi.org/10.1073/pnas.1013751108
26. Hoffmeyer K, Raggioli A, Rudloff S, Anton R, Hierholzer A, Del Valle I, Hein K, Vogt R, Kemler R. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 2012; 336:1549-54; PMID:22723415; http://dx.doi.org/10.1126/science.1218370
27. Zhang Y, Toh L, Lau P, Wang X. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/beta-catenin pathway in human cancer. J Biol Chem 2012; 287:32494-511; PMID:22854964; http://dx.doi.org/10.1074/jbc.M112.368282
28. Yu Y, Chen Y, Kim B, Wang H, Zhao C, He X, Liu L, LiuW,Wu LM, Mao M, et al. Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 2013; 152:248-61; PMID:23332759; http://dx.doi.org/10.1016/j.cell.2012.12.006
29. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009; 460:66-72; PMID:19571879; http://dx.doi.org/10.1038/nature08137
30. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23:3794-5; PMID:7479015; http://dx.doi.org/10.1093/nar/23.18.3794
31. Trotter KW, Archer TK. Nuclear receptors and chromatin remodeling machinery. Mol Cell Endocrinol 2007; 265-266:162-7; PMID:17240047; http://dx.doi.org/10.1016/j.mce.2006.12.015
32. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. Embo J 1996; 15:5370-82; PMID:8895581
33. Phelan ML, Sif S, Narlikar GJ, Kingston RE. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 1999; 3:247-53; PMID:10078207; http://dx.doi.org/10.1016/S1097-2765(00)80315-9
34. Hassan AH, Neely KE, Vignali M, Reese JC, Workman JL. Promoter targeting of chromatin-modifying complexes. Front Biosci 2001; 6:D1054-64; PMID:11532604; http://dx.doi.org/10.2741/Hassan
35. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E, Zhou B, Chang CP. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010; 466:62-7; PMID:20596014; http://dx.doi.org/10.1038/nature09130
36. Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 2011; 10:457-68; PMID:21248468; http://dx.doi.org/10.4161/cc.10.3.14707
37. Soria G, Almouzni G. Differential contribution of HP1 proteins to DNA end resection and homologydirected repair. Cell Cycle 2013; 12:422-9; PMID:23287531;http://dx.doi.org/10.4161/cc.23215
38. Ball AR, Jr., Yokomori K. Damage site chromatin: open or closed? Curr Opin Cell Biol 2011; 23:277-83; PMID:21489773; http://dx.doi.org/10.1016/j.ceb.2011.03.012
39. Baur JA, Zou Y, Shay JW, Wright WE. Telomere position effect in human cells. Science 2001; 292:2075-7; PMID:11408657; http://dx.doi.org/10.1126/science.1062329
40. Lou Z, Wei J, Riethman H, Baur JA, Voglauer R, Shay JW, Wright WE. Telomere length regulates ISG15 expression in human cells. Aging (Albany NY) 2009; 1:608-21; PMID:20157543
41. Spiegelman BM, Heinrich R. Biological control through regulated transcriptional coactivators. Cell 2004; 119:157-67; PMID:15479634; http://dx.doi.org/10.1016/j.cell.2004.09.037
42. Cuadrado A, Remeseiro S, Gomez-Lopez G, Pisano DG, Losada A. The specific contributions of cohesin- SA1 to cohesion and gene expression: implications for cancer and development. Cell Cycle 2012; 11:2233-8; PMID:22617390; http://dx.doi.org/10.4161/cc.20318
43. Felsenfeld G, Groudine M. Controlling the double helix. Nature 2003; 421:448-53; PMID:12540921; http://dx.doi.org/10.1038/nature01411
44. Berger SL. The complex language of chromatin regulation during transcription. Nature 2007; 447:407-12; PMID:17522673; http://dx.doi.org/10.1038/nature05915
45. Berger SL. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 2002; 12:142-8; PMID:11893486; http://dx.doi.org/10.1016/S0959-437X(02)00279-4
46. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004; 23:2919-33; PMID:15077154; http://dx.doi.org/10.1038/sj.onc.1207518
47. Yi X, Shay JW, Wright WE. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 2001; 29:4818-25; PMID:11726691; http://dx.doi.org/10.1093/nar/29.23.4818
48. Cristofari G, Lingner J. Telomere length homeostasis requires that telomerase levels are limiting. Embo J 2006; 25:565-74; PMID:16424902; http://dx.doi.org/10.1038/sj.emboj.7600952
49. Zhao Y, Abreu E, Kim J, Stadler G, Eskiocak U, Terns MP, Terns RM, Shay JW,Wright WE. Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions. Mol Cell 2011; 42:297-307; PMID: 21549308; http://dx.doi.org/10.1016/j.molcel.2011. 03.020
50. Romero OA, Setien F, John S, Gimenez-Xavier P, Gomez-Lopez G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-Cespedes M. The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. EMBO Mol Med 2012; 4:603-16; PMID:22407764; http://dx.doi.org/10.1002/emmm.201200236
51. Ouellette MM, Liao M, Herbert BS, Johnson M, Holt SE, Liss HS, Shay JW, Wright WE. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem 2000; 275:10072-6; PMID:10744686; http://dx.doi.org/10.1074/jbc.275.14.10072
52. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33:787-91; PMID:9282118; http://dx.doi.org/10.1016/S0959-8049(97)00062-2